By Fabian Koenigbauer ( October 18, 2024, 3:32 PM EDT) — On Oct. 7, the U.S. Supreme Court denied certiorari for In re: Cellect. As it stands, In re: Cellect and the Aug. 13 decision in Allergan USA Inc. v. MSN Laboratories Private are the most recent opinions from the U.S. Court of Appeals for the Federal Circuit governing obviousness-type double patenting, or ODP….

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.



Source link

Leave a Comment

Your email address will not be published. Required fields are marked *